(19)
(11) EP 2 273 975 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
17.12.2014 Bulletin 2014/51

(45) Mention of the grant of the patent:
09.04.2014 Bulletin 2014/15

(21) Application number: 09716304.2

(22) Date of filing: 02.03.2009
(51) International Patent Classification (IPC): 
A61K 9/08(2006.01)
 A61K 31/4015(2006.01)
(86) International application number:
PCT/EP2009/052454
(87) International publication number:
WO 2009/109547 (11.09.2009 Gazette 2009/37)

(54)

PHARMACEUTICAL SOLUTIONS, PROCESS OF PREPARATION AND THERAPEUTIC USES

PHARMAZEUTISCHE LÖSUNGEN, HERSTELLUNGSVERFAHREN DAFÜR UND THERAPEUTISCHE ANWENDUNGEN DAVON

SOLUTIONS PHARMACEUTIQUES, PROCÉDÉ DE PRÉPARATION ET UTILISATIONS THÉRAPEUTIQUES

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR
Designated Extension States:
BA RS

(30) Priority: 03.03.2008 EP 08003915

(43) Date of publication of application:
19.01.2011 Bulletin 2011/03

(73) Proprietor: UCB Pharma, S.A.
1070 Brussels (BE)

(72) Inventors:
  • SCHENKEL, Eric
    1070 Brussels (BE)
  • POULAIN, Claire
    1070 Brussels (BE)
  • DODELET, Bertrand
    1070 Brussels (BE)
  • FANARA, Domenico
    1070 Brussels (BE)


(56) References cited: : 
EP-A- 1 731 149
WO-A-2005/121082
 WO-A-01/62726
   
  • THEUER HAGEN ET AL: "Stabilitätsuntersuchungen von Piracetam-Infusionslösungen" PHARMAZEUTISCHE ZEITUNG, FRANKFURT, DE, vol. 132, no. 17, 1 January 1987 (1987-01-01), pages 1024-1029, XP002171959 ISSN: 0031-7136
 
Remarks:
The file contains technical information submitted after the application was filed and not included in this specification
 
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).